Provide Global Customers With
High-Quality Products And Comprehensive Pharmaceutical Services
Provide Related Products And Services Including 400+ Catalogue Products, Customized Synthetic Products And Generic Drugs Development And Transfer, Clinical Registration, Etc.
Provide Global Customers With
High-Quality Products And Comprehensive Pharmaceutical Services
Pharmaceutical
Services

ABOUT US
FarmaSino Pharmaceutical (Anhui) is a wholly-owned subsidiary of Jiangsu FarmaSino Pharmaceutical Co., Ltd., located in Suzhou Economic and Technological Development Zone, Anhui Province. The first phase covers an area of 50,000+square meters, with standard chemical synthesis workshops and API workshops meeting GMP production conditions.
The company is committed to closely integrating with the global market demand and providing high-quality products and comprehensive pharmaceutical services to global customers. With the advantages of technology and talents in chemical synthesis, process amplification, analysis and testing, preparation research and development, we have strong strength in antibacterial drugs, antiviral drugs, anti-tuberculosis drugs, anti-tumor drugs, cardiovascular drugs, diabetes and new product development, and provide related products and services including 400+ catalogue products, customized synthetic products and generic drugs, and clinical registration.
PRODUCTS
The company is committed to the research and development, production, import and export of raw materials and intermediates such as antibacterial drugs, antiviral drugs, anti-tuberculosis drugs, anti-tumor drugs, cardiovascular drugs, diabetes and new product development.
Development history

In 2015
Farmasino Pharmaceutical Company Was Established.

In 2016
Farmasino Pharmaceutical Company Was Established.

In 2019
Farmasino Pharmaceutical Company Was Established.

In 2021
Farmasino Pharmaceutical Company Was Established.

In 2022
Farmasino Pharmaceutical Company Was Established.
NEWS
The digital procurement system platform provides high-quality procurement guarantee for biopharmaceutical enterprises
With the continuous development and growth of the biopharmaceutical industry, procurement management has become an
National centralized procurement of drugs, lower prices! Reader: What is the efficacy of generic drugs?
In recent years, we have heard such new terms as "national centralized procurement", "4+7", and
What is the investment portfolio for innovative drugs in a non product pharmaceutical company that has risen by over 140%?
Pharmaceutical companies related to COVID-19 rose sharply today. Jiangsu Hengrui Medicine announced that it plans
The prices of traditional Chinese medicine have skyrocketed, and many pharmaceutical listed companies have “self built planting bases” that are not afraid of fluctuations
On May 16th, the Kangmei China Traditional Chinese Medicine Price Index was at 1987.3 points,